Company profile: Nanobiotix
1.1 - Company Overview
Company description
- Provider of nanomedicine therapeutics for the local treatment of cancer. Develops NanoXray, a technology using inert particles to destroy cancer cells. Products include magnetic particles and laser-activated nanoparticles for treatment and diagnostic. Offers NBTXR3, a radioenhancer that increases radiotherapy dose in tumor cells without affecting surrounding healthy tissues across solid tumors, and leads NANORAY-312, a phase 3 trial in HNSCC.
Products and services
- NanoXray: An inert-particle-based cancer therapy system that enables destruction of cancer cells, developed within Nanobiotix’s nanomedicine programs for local treatment of cancer
- NBTXR3: A tumor-localized radioenhancer engineered to increase radiotherapy dose absorption by tumor cells without affecting surrounding healthy tissues, used to treat various solid tumors
- NANORAY-312: Phase 3 clinical trial evaluating the efficacy and safety of NBTXR3 in patients with head and neck squamous cell carcinoma (HNSCC)
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nanobiotix
RadiaDyne
HQ: United States
Website
- Description: Provider of medical diagnostics and devices; privately held.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RadiaDyne company profile →
IconOVir Bio
HQ: United States
Website
- Description: Provider of preclinical oncolytic virus therapies for cancer, developing ICVB-1042, an oncolytic adenovirus for advanced solid tumors featuring tumor-selective replication, broad tropism, and enhanced tumor cell killing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IconOVir Bio company profile →
Capintec
HQ: United States
Website
- Description: Provider of calibration and measurement technologies for nuclear medicine applications, offering advanced technology and services with a commitment to continuous quality improvement, including the Captus® 4000e Thyroid Uptake System for measuring thyroid uptake.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Capintec company profile →
GigaGen
HQ: United States
Website
- Description: Provider of recombinant biotherapeutic discovery and development, advancing a pipeline of first-in-class biotherapeutics, including novel oncology antibody drug combinations and the world's first recombinant polyclonal hyperimmune gammaglobulin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GigaGen company profile →
Mirati Therapeutics
HQ: Canada
Website
- Description: Provider of novel cancer therapeutics in clinical development and commercialization; product candidates include MGCD265, an oral, multi-targeted kinase inhibitor targeting the Met, VEGF, Ron and Tie-2 receptor tyrosine kinases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mirati Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nanobiotix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nanobiotix
2.2 - Growth funds investing in similar companies to Nanobiotix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nanobiotix
4.2 - Public trading comparable groups for Nanobiotix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →